FDA Investigator Teena H Aiken

Teena H Aiken has conducted inspections on 179 sites in 13 countries as of 24 May 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
179
Last Inspection Date:
24 May 2024
Investigator Role:
FDA Investigator
Redica ID:
100005661
Countries of Inspections:
Netherlands, United States of America, Greece, France, Germany, Russian Federation, Italy, Belgium, Mexico, Spain, United Kingdom of Great Britain and Northern Ireland, Canada, Israel
FDA Investigators that have inspected at least one site in common with Teena H Aiken:
Alanna L Mussawwir Bias, Allen F Hall, Ana C Lazo, Andrea S Heise, Angela Shepas, Anthony N Onianwa, Arie C Menachem, Barbara D Wright, Barbara J Rincon, Barbara J White, Betty Kay Baxter, Blake R Jensen, Brent W Higgs, Brittany R Laymon, Bryan J Love, Carla R Hinz, Caroline H Le, Carolyn J Cook, Christine I Shaw, Christopher J Freebairn, Conor J Mccarron, Courtney R Bratina, Cynthia Jim, CSO, Cynthia L Rakestraw, Daniel J Lahar, Daniel Pst Laurent, Deborah B Nixon, Deborah M Trout, Deborah S Hammond, Debra L Curtis, Debra Lboyd Seale, Diane Cvan Leeuwen, Dianna D Wardlow Dotter, Don A Leeseberg, Dr. Abhijit Raha, PhD, Dr. Mark J Seaton, PhD, Dr. Sriram Subramaniam, PhD, Dr. Zhou Chen (nmi), MD PhD, Dustin P Tran, Dylan R Jock, Elaine G Stewart, Emily B Camire, Erin M Mcdowell, Erma Zaimova, Frank L Cordova, Garrad R Poole, George A Prager, Gerald N Mcgirl, DDS, Ginger M Sykes, Gloria A Milster, Hanna L Potter, Herminio C Francisco, Holly L Miller, Hugh M Mcclure, II, Isabel Y Espinosa, Isaiah D Isakson, James D Bradley, James R Fleckenstein, James R Montero, Jamie L Dion, Jeanne J Thai, Jennifer A Baker, Jessie E Morris, Joey V Quitania, Jonathan R Campos, Joo Jin, Julia D Cartwright, Kathleen S Tormey, Kathryn A Krentz, Kelly D Moore, Kent C Faul, Kevin D Kallander, Kimberley A Hoefen, Kimberly A Peterson, Kimetha A King, Kristen E Szenderski, Larisa E Pavlick, Laura B Kennedy, Laura L Staples, LCDR Ismael Olvera, IV, Linda M Cheny, Lori A Carr, Marc A Jackson, Jr, Margaret M Annes, Marion W Nadeau, Mary T Carden, Matthew J Gretkierewicz, Matthew M Vernon, Matthew R Dionne, Melissa J Nucci, Michael A Charles, Michael E Maselli, Michael J Kuchta, Michael L Zimmerman, Michael R Goga, Michelle L Safarik, MSPAS, PA C, RAC, Michelle Safarik, MSPAS, PA C, RAC, Mitzi A Schwertfeger, Nathan M Jornod, Nathan R Moon, Neira Acevedo Ramos, Ni Aye Khin, MD, Nicholas R Nance, Patricia A Brown, Patricia M Jacobs, Paul M Chefor, Paul Z Balcer, Prabhu P Raju, Rabia Ballica, PhD, Randy V Bong, Ricki A Chase, Ruth A Williams, Sandra L Shire, DMD, MPA, Shelley H Beausoleil, Sherri N Rohlf, MD, Shirley J Berryman, Srinivas R Chennamaneni, PhD, Sripal R Mada, PhD, Stefanie R Cook, Stephen T Hansen, Steven C Madzo, Sunitha K Rajaram, PhD, Susan L Young, Terri L Thomas, Thea C Grome, Theressa B Smith, Timothy C Grome, Trinidad D Barreras, Vien Q Le, William D Boden, William F Lagud, Jr, Zachary L Miller, Zachary L Stamm

Teena H Aiken's Documents

Publish Date Document Type Title
April, 2002 FDA 483 AlloSource - Form 483, 2002-04-01
March, 2007 FDA 483 Response Analytical Development Corp - Form 483R, 2007-04-10
May, 2001 EIR AlloSource - EIR, 2001-05-02
August, 2014 FDA 483 Response Michael W. Harris, D.O. - Form 483R, 2015-01-22
April, 2003 FDA 483 Feign, Michael, D.O. - Form 483, 2003-04-24
May, 2011 FDA 483 Michael W. Harris, D.O. - Form 483, 2011-09-29
January, 2005 FDA 483 Feign, Michael, D.O. - Form 483, 2005-01-28
February, 2008 EIR University of Colorado HSC Antiviral Pharmacology Laboratory - EIR, 2008-02-15
March, 2009 EIR ARCA biopharma, Inc. - EIR, 2009-03-09
September, 2007 EIR Aliri USA Inc. - EIR, 2007-11-19
May, 2011 EIR Michael W. Harris, D.O. - EIR, 2011-05-03
July, 2014 FDA 483 Derek D. Muse, M.D., Clinical Investigator - Form 483, 2014-07-18
August, 2012 EIR CARE Research, LLC - EIR, 2012-08-22
January, 2005 EIR Feign, Michael, D.O. - EIR, 2005-01-28
April, 2003 EIR Feign, Michael, D.O. - EIR, 2003-04-24
March, 2009 FDA 483 Response ARCA biopharma, Inc. - Form 483R, 2009-04-03
March, 2007 FDA 483 Analytical Development Corp - Form 483, 2007-03-22
May, 2013 FDA 483 Response Univ Of NM School Of Medicine Human Research Review Committe - Form 483R, 2013-06-06
May, 2011 FDA 483 Response Michael W. Harris, D.O. - Form 483R, 2011-05-12
December, 2004 FDA 483 Rocky Mountain Lions Eye Bank - Form 483, 2004-12-16
June, 2009 EIR Aliri USA Inc. - EIR, 2009-06-04
August, 2006 FDA 483 Replidyne, Inc. - Form 483, 2006-08-08
October, 2006 FDA 483 Replidyne, Inc. - Form 483, 2006-10-17
May, 2013 FDA 483 Univ Of NM School Of Medicine Human Research Review Committe - Form 483, 2013-05-15
March, 2003 EIR Redbeast Enterprises Inc dba High Quality Research - EIR, 2003-03-13
August, 2014 EIR Michael W. Harris, D.O. - EIR, 2014-08-29
March, 2009 FDA 483 ARCA biopharma, Inc. - Form 483, 2009-03-09
March, 2007 EIR Analytical Development Corp - EIR, 2007-03-22

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more